Pharmaceuticals - Indian - Formulations
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 47.07 | 44.47 | 34.48 | 32.87 | 30.20 |
Total Expenses | 43.27 | 40.75 | 30.68 | 32.12 | 29.71 |
Profit Before Tax | 3.80 | 3.72 | 3.80 | 0.75 | 0.50 |
Profit After Tax | 3.31 | 2.81 | 2.81 | 0.54 | 0.36 |
Operating Profit after Depreciation | 4.63 | 5.14 | 5.88 | 1.98 | 1.66 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 12.47 | 6.80 | 7.13 | 6.50 | 5.05 |
Total Non Current Assets | 13.51 | 7.92 | 8.96 | 8.55 | 5.96 |
Total Current Assets | 43.13 | 41.14 | 39.30 | 20.46 | 18.37 |
TOTAL ASSETS | 56.64 | 49.06 | 48.26 | 29.01 | 24.33 |
Total Shareholder's Fund | 35.58 | 32.27 | 11.29 | 6.87 | 5.38 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 8.36 | -9.07 | 2.32 | -5.87 | 3.21 |
Net Cash used in Investing Activities | -6.07 | 0.87 | -0.71 | -1.64 | -2.76 |
Net Cash used in Financing Activities | -2.31 | 8.07 | -1.46 | 7.25 | -0.19 |
No data available
No data available
₹0.25/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
JFL Life Sciences Ltd | ₹21.60 | ₹71.27 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
07 Nov 2024, 10:23 am
02 Sep 2024, 10:53 am
24 Aug 2024, 11:18 am
02 Aug 2024, 04:56 pm
27 Jul 2024, 10:44 am